Patents by Inventor Kirk Kimmerling

Kirk Kimmerling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230329978
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Application
    Filed: May 8, 2023
    Publication date: October 19, 2023
    Inventors: Franklin R. Tay, Shi-qiang Gong, Kirk Kimmerling
  • Patent number: 11679064
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared front the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: June 20, 2023
    Assignee: KIMMERLING HOLDINGS GROUP, LLC
    Inventors: Franklin R. Tay, Shi-qiang Gong, Kirk Kimmerling
  • Publication number: 20220118095
    Abstract: Methods of reducing dermal penetration of at least one active ingredient in a topically applied product using compositions comprising siloxane polymers are disclosed. In some aspects, the active ingredient is an antimicrobial agent, especially benzalkonium chloride, 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride, and combinations thereof.
    Type: Application
    Filed: June 23, 2021
    Publication date: April 21, 2022
    Inventor: Kirk A. Kimmerling
  • Publication number: 20220041811
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared front the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Application
    Filed: April 26, 2021
    Publication date: February 10, 2022
    Inventors: Franklin R. Tay, Shi-qiang Gong, Kirk Kimmerling
  • Patent number: 10995181
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: May 4, 2021
    Assignee: KIMMERLING HOLDINGS GROUP, LLC
    Inventors: Franklin R. Tay, Shi-Qiang Gong, Kirk Kimmerling
  • Patent number: 10780169
    Abstract: Methods of reducing dermal penetration of at least one active ingredient in a topically applied product using compositions comprising siloxane polymers are disclosed. In some aspects, the active ingredient is an antimicrobial agent, especially benzalkonium chloride, 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride, and combinations thereof.
    Type: Grant
    Filed: April 2, 2020
    Date of Patent: September 22, 2020
    Assignee: Kimmerling Holdings Group, LLC
    Inventor: Kirk A. Kimmerling
  • Publication number: 20200230243
    Abstract: Methods of reducing dermal penetration of at least one active ingredient in a topically applied product using compositions comprising siloxane polymers are disclosed. In some aspects, the active ingredient is an antimicrobial agent, especially benzalkonium chloride, 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride, and combinations thereof.
    Type: Application
    Filed: April 2, 2020
    Publication date: July 23, 2020
    Inventor: Kirk A. KIMMERLING
  • Publication number: 20190276606
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Application
    Filed: January 7, 2019
    Publication date: September 12, 2019
    Inventors: Franklin R. Tay, Shi-qiang Gong, Kirk Kimmerling
  • Publication number: 20190105394
    Abstract: Methods of reducing dermal penetration of at least one active ingredient in a topically applied product using compositions comprising siloxane polymers are disclosed. In some aspects, the active ingredient is an antimicrobial agent, especially benzalkonium chloride, 3-(trimethoxysilyl) propyldimethyloctadecyl ammonium chloride, and combinations thereof.
    Type: Application
    Filed: September 17, 2018
    Publication date: April 11, 2019
    Inventor: Kirk A. Kimmerling
  • Patent number: 10189954
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: January 29, 2019
    Assignee: Kimmerling Holdings Group, LLC
    Inventors: Franklin R. Tay, Shi-qiang Gong, Kirk Kimmerling
  • Patent number: 10159630
    Abstract: Compositions are disclosed that comprise at least one compound of formula IV: wherein the variable are as defined in the specification. The compositions are antimicrobial and optionally curable, and useful, inter alia, in dental, medical, and industrial applications for reinforcement and/or adhering two surfaces together.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: December 25, 2018
    Assignee: Kimmerling Holdings Group, LLC
    Inventors: John D. Blizzard, Kirk Kimmerling, Joseph P. Rapp
  • Publication number: 20180064738
    Abstract: Pharmaceutical compositions are disclosed that comprise at least one compound of formula I: wherein the substituent groups are as defined in the specification, and a pharmaceutically-acceptable excipient. The disclosed pharmaceutical compositions are anti-infective and useful as therapies for the treatment of an infection, including infections associated with a bacteria or a virus. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: October 7, 2015
    Publication date: March 8, 2018
    Inventors: Bhupesh Kumar PRUSTY, Dharam V. ABLASHI, Kirk KIMMERLING
  • Publication number: 20160199266
    Abstract: Compositions are disclosed that comprise at least one compound of formula IV: wherein the variable are as defined in the specification. The compositions are antimicrobial and optionally curable, and useful, inter alia, in dental, medical, and industrial applications for reinforcement and/or adhering two surfaces together.
    Type: Application
    Filed: March 10, 2016
    Publication date: July 14, 2016
    Inventors: John D. Blizzard, Kirk Kimmerling, Joseph P. Rapp
  • Publication number: 20160176902
    Abstract: One-pot synthetic methods are disclosed for synthesizing curable, antimicrobial silsesquioxane-silica hybrids by hydrolytically co-condensing a tetraalkoxysilane with two different trialkoxysilanes. Particles are also disclosed that are substantially spherical and have an ordered lamellar internal structure. In addition, polymers prepared from the curable, antimicrobial silsesquioxane-silica hybrids and co-monomers are disclosed.
    Type: Application
    Filed: August 15, 2014
    Publication date: June 23, 2016
    Inventors: Franklin R. TAY, Shi-qiang GONG, Kirk KIMMERLING
  • Patent number: 9314407
    Abstract: Compositions are disclosed that comprise at least one compound of formula IV: wherein the variable are as defined in the specification. The compositions are antimicrobial and optionally curable, and useful, inter alia, in dental, medical, and industrial applications for reinforcement and/or adhering two surfaces together.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: April 19, 2016
    Assignee: KIMMERLING HOLDINGS GROUP, LLC
    Inventors: John D. Blizzard, Kirk Kimmerling, Joseph P. Rapp
  • Publication number: 20130230676
    Abstract: Compositions are disclosed that comprise at least one compound of formula IV: wherein the variable are as defined in the specification. The compositions are antimicrobial and optionally curable, and useful, inter alia, in dental, medical, and industrial applications for reinforcement and/or adhering two surfaces together.
    Type: Application
    Filed: August 24, 2012
    Publication date: September 5, 2013
    Inventors: John D. Blizzard, Kirk Kimmerling, Joseph P. Rapp